Agreement - November 30, 2020
Alvotech enters biosimilar partnership in China
Alvotech and Alvotech & CCHT Biopharmaceutical, which is the China joint venture company of Alvotech hf. and Changchun High & New Technology Industries (Group) Inc., have partnered with Yangtze River Pharmaceutical Group to form an exclusive strategic partnership for the commercialization of eight biosimilar medicines in China. The initial pipeline contains biosimilar candidates for treatment […]
Agreement - October 5, 2020
Alvotech extends partnership with DKSH
Alvotech and DKSH have announced an expansion of their strategic partnership to commercialize six new biosimilar product candidates for the Asian markets. The initial pipeline contains biosimilar candidates addressing multiple therapeutic areas. “We have been delighted to work with DKSH since our initial partnership began earlier this year. The partnership is designed to accelerate improved […]
Agreement - September 1, 2020
Alvotech enters strategic partnership with Teva
The collaboration, announced in August, is one of the broadest partnerships within the U.S. biosimilar industry to date to accelerate improved patient access for high quality biosimilar medicines in the U.S. biosimilar industry. Alvotech and Teva Pharmaceutical Industries have entered into an exclusive strategic partnership for the commercialization in the U.S. of five biosimilar product […]
CDMO - February 7, 2020
A CDMO with a competitive edge
Coripharma has taken the positive lessons learned from Iceland’s history and excellence in pharmaceutical manufacturing and aims to bring a competitive edge to this solid heritage. Over past decades Iceland has proven successful in the field of R&D development and manufacturing of pharmaceuticals and generics. Invest in Iceland reports that investments in R&D manufacturing within […]
Iceland - October 13, 2017
Reykjavik – A unique life science environment
Despite some years of really struggling financially, Iceland has been able to maintain its position as a provider of unique experimental settings for drug discovery. Today life science in the country has never been stronger. Looking back 20-30 years the country has witnessed a dramatic leap forward within life science. Back then there were a […]
Iceland - December 2, 2016
Study results from BRCA2 mutation carriers
Researchers have published findings about estrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers. The impact of an inherited BRCA2 mutation on the prognosis of women with breast cancer has not been well documented. The researchers studied the effects of estrogen receptor (ER) status, other prognostic factors and treatments on survival […]
